marketing-medtech

**Founder:** Nisrine Ghemrawi — Présidente (Président de SAS)
**Background:** pharma_medtech_exec | verified: True — Pharmaceutical industry executive / Medical Affairs professional. Nisrine Ghemrawi holds a PharmD (Doctor of Pharmacy, Lebanese University, 1999-2004) and an MBA (EDHEC Global MBA). Her LinkedIn headline reads "Nisrine GHEMRAWI, PharmD, MBA - Medical Affairs and...". She has held roles at major pharmaceutical companies Novartis and Bayer, with skills in Pharmaceutical Industry, Pharmaceutical Sales, Product Launch, Sales Effectiveness, and Cardiology. She is currently Project Lead at Iterra and is Présidente (founder) of INREV HEALTH, a clinical-research SAS (clinical trial monitoring, quality control, and clinical research project management). The "pharma" portion of the claim is strongly supported; her documented background is pharmaceutical/medical affairs rather than medical devices (medtech) specifically, but the combined pharma_medtech executive category is supported.
**Stage / fundraise:** Very early stage. SAS incorporated 2025-05-16 (SIREN 944618115), ~13 months old as of June 2026, single establishment in Sèvres (92310), no recorded employees (tranche effectif "NN"), NAF 72.19Z (R&D / scientific services). Pre-revenue, founder-run. / No public fundraise evidence found
**Regulatory trigger:** Company object is squarely regulatory/quality-driven: per its legal notice, INREV HEALTH conducts on-site clinical trials, scientific/technical/regulatory quality control of clinical research projects, manages a portfolio of clinical research and epidemiology studies, and provides clinical-research assistance (CRO-type services). This is a CRO / clinical-quality services play rather than a confirmed SaMD product — the IEC 62304/MDR build-evidence angle only applies if/when they build a software platform (e.g., an eTMF/eCRF, EDC, or patient-facing tool). Regulatory mindset is high; SaMD-product fit is unconfirmed.
**Email:** (confidence none) — No published email address and no company domain/website were found for INREV HEALTH (searches for inrev-health / inrevhealth.com / inrev.health returned nothing relevant). No verifiable email pattern exists, so no address is provided. Best contact route is LinkedIn DM/connection to Nisrine Ghemrawi.
**LinkedIn:** https://fr.linkedin.com/in/nisrine-ghemrawi **Website:**
**Score:** 10 -> Tier B
**Hook:** Nisrine — you launched INREV HEALTH in 2025 to deliver clinical-research operations and regulatory quality control, and as a PharmD/MBA from the Novartis/Bayer world you know that this work lives or dies on traceability and audit-readiness. The gap most clinical-quality founders hit is software: you can't scale on-site trials, study portfolios, and QC manually, and hiring a dev team plus a CTO is slow and expensive. OmDev gives you a senior dev team AND a dedicated CTO on a fixed monthly price (~3x cheaper than building in-house, you own the code) — and for regulated builds our pipeline produces compliance evidence by default (signed SOUP register at every build, requirements-to-code-to-test traceability feeding an IEC 62304/MDR file). That turns your regulatory expertise into a defensible product instead of a service you deliver by hand.

---

## Founder & background
Nisrine Ghemrawi (b. 1979) is the sole founder/Présidente of INREV HEALTH ([gouv.fr API, SIREN 944618115](https://recherche-entreprises.api.gouv.fr/search?q=944618115)). She is a **PharmD (Lebanese University, 1999-2004) + MBA** with a **Medical Affairs** career including roles at **Novartis and Bayer** ([LinkedIn](https://fr.linkedin.com/in/nisrine-ghemrawi); [RocketReach](https://rocketreach.co/nisrine-ghemrawi-email_223402692)). Strong ex-pharma / regulatory-literate executive profile (high-priority background, just below finance/insurance). Serial-founder signal: she also founded NUTRI AND NATU ([societe.com](https://www.societe.com/societe/nutri-and-natu-900610601.html)). Non-technical founder.

## Funding & momentum
SAS incorporated **2025-05-16** in Sèvres (92310), ~13 months old, single establishment, **no recorded employees** ([gouv.fr API](https://recherche-entreprises.api.gouv.fr/search?q=944618115)). **No public fundraise evidence** was found — no press, no investor announcement. Treat "actively fundraising" as unconfirmed; currently appears bootstrapped/founder-led.

## Product & regulatory
No website or product found. Per its legal notice, the objet social is **clinical-research operations and regulatory/scientific quality control**: running on-site trials, QC of clinical research projects, managing a portfolio of clinical research + epidemiology studies, and clinical-research assistance ([mesinfos legal notice](https://mesinfos.fr/consulter-annonces-legales/ile-de-france/92-hauts-de-seine/inrev-health-14caf3ca99aecb7b96431c5e0a6370a4bd97aa20)). This is a **CRO / clinical-quality services** play, not a confirmed SaMD product — so the IEC 62304/MDR evidence angle applies only if they build a software platform (EDC/eCRF, eTMF, study dashboards).

## Pain & buying signals
Non-technical solo founder, **no CTO, no dev team / zero recorded employees**; a clinical-research/quality business that needs software (EDC, eTMF, portfolio/traceability tooling) to scale past manual delivery; deeply regulatory-literate founder who will immediately grasp the value of built-in compliance evidence.

**Why OmDev fits:** OmDev supplies a senior dev team **plus a dedicated CTO** at a fixed monthly price (~3x cheaper than hiring in-house, client owns the code). For any regulated build, the pipeline ships compliance evidence by default — signed SOUP register at every build and requirements-to-code-to-test traceability feeding an IEC 62304/MDR file — letting Nisrine convert her regulatory expertise into a scalable software product rather than hand-delivered services. (OmDev builds the evidence; it does not certify.) Best outreach channel: LinkedIn (no published email found).

---
**Sources:** https://recherche-entreprises.api.gouv.fr/search?q=944618115 · https://fr.linkedin.com/in/nisrine-ghemrawi · https://rocketreach.co/nisrine-ghemrawi-email_223402692 · https://www.pappers.fr/dirigeant/nisrine_ghemrawi_1979-10 · https://mesinfos.fr/consulter-annonces-legales/ile-de-france/92-hauts-de-seine/inrev-health-14caf3ca99aecb7b96431c5e0a6370a4bd97aa20 · https://www.societe.com/societe/nutri-and-natu-900610601.html